Partner Content Partner Content J+D Forecasting launches innovative pharmaceutical sales for... Sales+ is the first Excel add-in that provides all the
Views & Analysis 5 years of biosimilars in the US: what have we learned? Biologics have created revolutionary treatment options that have transformed the care journey for hundreds of millions of patients worldwide.
News Pfizer launches biosimilars to Roche's 'big three' cancer dr... Pfizer has announced the launch of its competitors to Roche’s ‘big three’ cancer drugs in the US, at a “substantially discounted price” compared with the originators.
Partner Content Partner Content New Dates Released for J+D's Pharma Forecasting Training J+D releases new forecasting training dates
Views & Analysis Nine pharma trends for 2020 Sarah Rickwood looks back at how pharma changed over the last decade and what this might mean for the industry in 2020.
Views & Analysis The 4 biggest pharma market access stories of 2019 What events have defined the market access landscape in 2019, and what trends will shape 2020? We dive into the pharmaphorum archives to find out.
Sales & Marketing Biotech is back, with Craig Ackerman In Philadelphia this month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
